Lataa...
Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
SIMPLE SUMMARY: Hepatocellular carcinoma is the most common liver malignancy. In the population with an advanced stage of the disease, outcomes could be disappointed by treating with molecular targeting agents because of low treatment response rates. It has gained improving effects of immune checkpo...
Tallennettuna:
| Julkaisussa: | Cancers (Basel) |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036568/ https://ncbi.nlm.nih.gov/pubmed/33807219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071607 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|